OTC : EKDHF

EKF Diagnostics Holdings plc

$0.3469 USD

$0 (0.0%)

Volume
20K
Average Volume
983
Market Capitalization
$149.28M
P/E Ratio
53.62
Dividend Yield
0.00%
Price Target
Year High
$0.42
Year Low
$0.29
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$4.16
Company Overview

OTC

Gavin Joseph Jones

Medical - Devices

Healthcare

EKDHF

301

GB

USD

https://www.ekfdiagnostics.com

44 29 2071 0570

N/A

N/A

Liquidity Metrics

0.02

4.16

3.04

2.13

0.00

Sales & Valuation

$51.56M

2.10

1.64

13.26

0.02

Profitability

$0.0047

$2.12M

4.12%

13.74%

3.01%

2.62%

P/E Metrics

53.62

-0.81

-0.81

Analyst Price Target & Rating

N/A

0/5

0 Analysts

%

Poll Results

About EKF Diagnostics Holdings plc (OTC:EKDHF) Stock

EKF Diagnostics Holdings plc, a company founded in Cardiff, United Kingdom in 1990, specializes in the global design, development, manufacture, and sale of diagnostic instruments, reagents, and supporting products. Operating across Europe, the Middle East, the Americas, Asia, and Africa, the company offers a comprehensive range of solutions for clinical diagnostics. Their product line encompasses various diagnostic tools, including hemoglobin analyzers such as the hand-held DiaSpect Tm, DiaSpect Hemoglobin T, and the lab-quality Hemo Control, alongside the HemataStat II microhematocrit centrifuge. For diabetes management and monitoring, EKF provides glycated hemoglobin analyzers like Quo-Lab A1c and Quo-Test A1c, in addition to glucose and lactate analyzers such as the Biosen C-Line GP+, C ... -Line Clinic, and Lactate Scout 4. The company also manufactures specialized analyzers, including the STAT-Site M Beta-hydroxybutyrate analyzer, Creamatocrit Plus for assessing lipid concentration and calorific density in mothers' milk, and pregnancy tests like QuPID and True20. EKF's portfolio extends to clinical chemical analyzers and reagents covering ketosis monitoring (Beta-hydroxybutyrate, Nitro-tab Ketone tablets), Glycated Albumin, Glycated Serum Protein, and Procalcitonin, a marker for bacterial infection and sepsis. Additional offerings include RaPET Serology immunoassay kits, rapid tests like QuStick Strep A for Strep A infections, and various laboratory instruments such as the Altair 240 chemistry analyzer, Excel semi-automated chemistry analyzer, and Micro 12 centrifuge. EKF also supplies Hema-Screen Serology for early colorectal cancer detection, the Uri-Trak 120 urine analyzer, and provides kits and services related to COVID-19. Beyond product sales, the company offers contract manufacturing solutions to third-party businesses and provides laboratory services.

Frequently Asked Questions

What is the current EKF Diagnostics Holdings plc (EKDHF) stock price?

EKF Diagnostics Holdings plc(OTC:EKDHF) stock price is $0.3469 in the last trading session. During the trading session, EKDHF stock reached the peak price of $0.42365 while $0.2939 was the lowest point it dropped to. The percentage change in EKDHF stock occurred in the recent session was 0.0% while the dollar amount for the price change in EKDHF stock was $0.

EKDHF's industry and sector of operation?

The OTC listed EKDHF is part of Medical - Devices industry that operates in the broader Healthcare sector.

Who are the executives of EKDHF?

Gavin Joseph Jones | Chief Executive Officer & Director
Julian Huw Baines | Executive Chairman
Helen Mary Kinsey Jones | Chief Financial Officer & Director
|
|

How many employees does EKDHF have?

Number of EKDHF employees currently stands at 301. EKDHF operates from Avon House, Cardiff, None CF64 2EZ, GB.

Link for EKDHF official website?

Official Website of EKDHF is: https://www.ekfdiagnostics.com

How do I contact EKDHF?

EKDHF could be contacted at phone #44 29 2071 0570 and can also be accessed through its website. EKDHF operates from Avon House, Cardiff, None CF64 2EZ, GB.

How many shares of EKDHF are traded daily?

The average number of EKDHF shares traded daily for last 3 months was 983.

What is the market cap of EKDHF currently?

The market value of EKDHF currently stands at $149.28M with its latest stock price at $0.3469